Literature DB >> 1735525

Portal-vein obstruction in children leads to growth retardation.

S K Sarin1, A Bansal, S Sasan, A Nigam.   

Abstract

The portal vein is the main source of blood and hepatotrophic factors to the liver. Partial portal-vein ligation in rats results in reduced growth compared with that in control rats. To investigate whether extrahepatic portal vein obstruction occurring in early childhood influences growth in humans, anthropometric and nutritional assessments were prospectively carried out in 61 patients with extrahepatic portal vein obstruction. Comparisons were made with 183 matched healthy controls using National Center of Health Statistics reference. Fifty-one percent of children with extrahepatic portal vein obstruction had stunted growth (height for age less than 90% of normal), compared with 16% of controls (p less than 0.01). Growth retardation was severe in patients with longer (greater than 5 yr) than with shorter (less than 2.5 yr) duration of clinical portal hypertension (height for age, 88.0 +/- 3.2 vs. 95.1 +/- 3.0; p less than 0.01). Little difference was seen in the energy intake (1,302 +/- 463 kcal/day vs. 1,335 +/- 449 kcal/day; p = not significant) and weight for height index (83.6 +/- 9.3 vs. 88.0 +/- 7.9; p = not significant) between extrahepatic portal vein obstruction patients and controls. This suggested that despite comparable nutrition, marked growth retardation occurred in extrahepatic portal vein obstruction patients. Incremental growth velocity was studied in 31 patients; in 24 (73%) the baseline Z score (-2.1 +/- 0.2) had decreased further (-2.4 +/- 0.2) at the end of follow-up (15.5 +/- 1.6 mo). Although the incremental height velocity was only 56% of the expected height, incremental weight gain was 98% of the expected weight for the attained height.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1735525     DOI: 10.1002/hep.1840150210

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

Review 1.  Long term management of oesophageal varices.

Authors:  S K Sarin
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 2.  Extrahepatic Portal Venous Obstruction: What Should be the Mainstay of Treatment?

Authors:  Richa Lal; Moinak Sen Sarma; Manish K Gupta
Journal:  Indian J Pediatr       Date:  2017-06-14       Impact factor: 1.967

3.  Extrahepatic portal venous obstruction: is the knife irrelevant?

Authors:  Sujoy Pal; Peush Sahni
Journal:  Indian J Gastroenterol       Date:  2009-12

4.  Current role of surgery in portal hypertension.

Authors:  Sujoy Pal
Journal:  Indian J Surg       Date:  2011-12-13       Impact factor: 0.656

5.  Revisiting extra hepatic portal vein obstruction in children from the north Indian gangetic plain.

Authors:  Sundeep Goyal; V K Dixit; A K Jain; O P Mishra; S K Jena; Jayant Ghosh
Journal:  Indian J Pediatr       Date:  2013-10-10       Impact factor: 1.967

Review 6.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

7.  Surgical treatment of massive splenomegaly and severe hypersplenism secondary to extrahepatic portal venous obstruction in children.

Authors:  Roy Choudhury Subhasis; Chadha Rajiv; Sharma Akshay Kumar; Anand Vinod Kumar; Patwari Ashok Kumar
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

8.  Portal hypertensive biliopathy: Can we prevent it?

Authors:  K L N Rao; B R Thapa
Journal:  J Indian Assoc Pediatr Surg       Date:  2010-01

9.  Extrahepatic portal hypertension in children: observations on three surgical procedures.

Authors:  K L N Rao; Anju Goyal; Prema Menon; B R Thapa; K L Narasimhan; S K Chowdhary; R Samujh; J K Mahajan
Journal:  Pediatr Surg Int       Date:  2004-09-04       Impact factor: 1.827

Review 10.  Current state of portosystemic shunt surgery.

Authors:  Martin Wolff; Andreas Hirner
Journal:  Langenbecks Arch Surg       Date:  2003-03-29       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.